Medicare IVIG Access Enhancement Act of 2025
- house
- senate
- president
Last progress February 7, 2025 (10 months ago)
Introduced on February 7, 2025 by Adrian Smith
Sponsors (3)
House Votes
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Senate Votes
Presidential Signature
AI Summary
This bill would expand Medicare so it can cover intravenous immune globulin (IVIG) treatments given at home, instead of only in clinics. It aims to make it easier and safer for people to get these infusions without long trips or exposure to germs in medical settings. The coverage specifically includes IVIG for certain nerve disorders, like chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy, which can cause muscle weakness and numbness. It also lets Medicare adjust payment rates to better fit the costs of giving IVIG in a home setting.
Key points
- Who is affected: Medicare beneficiaries who need IVIG for CIDP or multifocal motor neuropathy.
- What changes: Medicare coverage would include IVIG given at home, with flexibility in payments to support home-based care.
- Why it matters: Easier access to needed infusions, less travel, and fewer clinic visits for people with ongoing nerve conditions.